Jacobs Levy Equity Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1M Buy
391,212
+52,318
+15% +$1.98M 0.06% 252
2026
Q1
$12.1M Buy
+338,894
New +$12.3M 0.05% 279
2022
Q3
Sell
-243,503
Closed -$17.2M 1034
2022
Q2
$17.2M Buy
243,503
+142,657
+141% +$11.5M 0.13% 192
2022
Q1
$9.28M Buy
+100,846
New +$9.47M 0.06% 308
2018
Q2
Sell
-21,810
Closed -$2.27M 1037
2018
Q1
$2.27M Buy
+21,810
New +$2.54M 0.04% 448

Other funds holding CRI

Jacobs Levy Equity Management's CRI Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Carter's (CRI) stake by 15% in Q2 2026, buying an estimated $1.98M and bringing the position to 391,212 shares worth $16.1M. The position accounts for 0.06% of the portfolio, ranked #252.

Jacobs Levy Equity Management first reported a position in CRI in Q1 2018 and has held it in 5 quarters since. The position peaked at $17.2M in Q2 2022. 288 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Jacobs Levy Equity Management held 391,212 shares of Carter's worth $16.1M as of Q2 2026.
  • Jacobs Levy Equity Management bought 52,318 Carter's shares in Q2 2026, an estimated $1.98M.
  • Carter's made up 0.06% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #252 holding.
  • Jacobs Levy Equity Management first reported a position in Carter's in Q1 2018 and has held it in 5 quarters since.
  • Jacobs Levy Equity Management's Carter's position peaked at $17.2M in Q2 2022.
  • 288 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.